Zealand Pharma A/S
Where can equity investors hide as Israel and Iran take aim at each other?
As equity markets broadly declined after Israel and Iran took aim at each other – some sectors and stocks are bucking the trend. The attack, which reportedly killed senior Iranian military and scientific figures, prompted an immediate flight to safety in financial markets. Brent crude , the international oil benchmark, jumped 7% to $78.50 a […]
Read More
Roche shares pop 4% on $5.3 billion obesity drug deal with Zealand Pharma
Swiss pharmaceutical giant Roche said Wednesday that it had struck a deal worth up to $5.3 billion to develop Danish biotech Zealand Pharma’s obesity drug candidate, as the two firms seek to compete in the burgeoning weight loss drug market. The deal will see the two companies co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as […]
Read More
European markets rally as U.S. inflation rises less than expected, EU retaliates to Trump’s tariffs
U.S. inflation rate hits 2.8% in February, less than expected Prices for goods and services moved up less than expected in February, providing some relief as consumers and businesses worry about the looming impact tariffs might have on inflation, the Bureau of Labor Statistics reported Wednesday. The consumer price index, a wide-ranging measure of costs across […]
Read More
Healthy Returns: AbbVie is the newest potential weight loss drug market player
A sign stands outside an Abbvie facility in Cambridge, Massachusetts. Brian Snyder | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. The booming weight loss drug market has gained a new potential competitor. AbbVie […]
Read More
The ‘weight-loss trade’ has stalled. What it will take to revive investor interest
Anyone who’s been on a diet can likely relate: Those first lost pounds are met with a sense of euphoria. The voice inside one’s head screams: “I’ve got this!” But then, it inevitably becomes a slog. The initial novelty wears off, and the real work begins. Investors may see a parallel to the initial elation […]
Read More
Wegovy and Zepbound rival targeting ‘next generation’ of obesity drugs, Zealand Pharma CEO says
Danish biotech Zealand Pharma is targeting the “next generation” of weight loss drugs as competitors pile into a market dominated by heavyweights Novo Nordisk and Eli Lilly. CEO Adam Steensberg told CNBC Thursday that early-stage trials of its experimental obesity injection point to higher-quality weight loss — with reduced muscle loss and fewer side effects — […]
Read More
Healthy Returns: Here’s what GLP-1s are being tested for beyond weight loss, diabetes
Weight loss syringes of the brands “Wegovy”, “Ozempic” and “Mounjaro” are sold at In der Achat Apotheke in Mitte, Germany. Picture Alliance | Picture Alliance | Getty Images Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Good afternoon! The list of potential health benefits from […]
Read More
Beyond Novo and Eli Lilly: Watch these biotech and weight loss drug names, fund manager says
Weight loss drugs have drawn investor interest and shaken up other sectors in the past year or so. Novo Nordisk and Eli Lilly were two early winners of this trend, as their drugs dominate the weight loss drug market. Yuri Khodjamirian, fund manager at Tema ETFs, said both companies are a “very powerful duopoly.” “But […]
Read More
Novo Nordisk and Eli Lilly shares slide on new obesity drug trial from Roche
Novo Nordisk and Eli Lilly shares slid Wednesday after Roche announced promising early-stage trial data from its latest obesity drug candidate. The Swiss pharmaceutical giant said Wednesday that a second drug candidate from its purchase of Carmot Therapeutics indicated positive results, further heating up competition in the weight loss drug market. Roche shares jumped in […]
Read More
Healthy Returns: Brain implant company Paradromics launches patient registry ahead of human trial
Think a friend or colleague should be getting this newsletter? Share this link with them to sign up. Aamir Ahmed Khan, PhD, Principal Electrical Engineer for Paradromics, works on the Transceiver which connects to the brain implants. Austin based Paradromics is developing a brain-computer interface to aide disabled and non-verbal patients with communication. Julia Robinson […]
Read More